Related Case Studies
Clinical Guideline Strategy
IP leveraged its Medical Affairs expertise and experience supporting more than 70 submissions to key oncology clinical practice guidelines to advocate for the inclusion of a test that predicts the benefit of therapy, resulting in broad and appropriate access for patients.
View All Case Studies
- Assessing Market Potential
- MSL Trainings
- Conference Engagement Strategy
- KOL Development
- Guideline Advocacy Strategy
- Clinical Guideline Strategy
- Engaging Community and Academic Physicians in Preparation for Product Launch
- Understanding the Patient Journey and Pain Points in Diagnosis
- Collecting KOL Insights Into Trial Design
- Healthcare Policy Changes Interpreted in Real-Time
- A Comprehensive Launch Strategy Leads to Broad Access
- Understanding the European Market
- Insight Into a New Therapeutic Landscape
- Strategizing a Change in a Company’s Focus
- A Novel Therapy Seeks to Support Physician Reimbursement
- The Case is Made for New CPT Codes
- A Successful Transition from Europe to the US Market
- A First of its Kind Approval Changes the Way We Think About Access